Ordinance
on Clinical Trials
with the exception of
Clinical Trials of Medical Devices1
(Clinical Trials Ordinance, ClinO)

of 20 September 2013 (Status as of 26 May 2022)

1 Amended by Annex 2 No 2 of the O of 1 July 2020 on Clinical Trials with Medical Devices, in force since 26 May 2021 (AS 2020 3033).


Open article in different language:  DE  |  FR  |  IT
Art. 56 Special provisions for clinical trials of the transplantation of embryonic or foetal tissues and cells

1 The FOPH shall grant au­thor­isa­tion if, in ad­di­tion to Art­icle 53, the re­quire­ments spe­cified in Art­icle 34 of the Trans­plant­a­tion Or­din­ance of 16 March 200744 are met.

2 It shall grant au­thor­isa­tion with­in 60 days or, in the case of sig­ni­fic­ant changes, with­in 30 days after re­ceipt of the com­plete ap­plic­a­tion doc­u­ments.

3 For clin­ic­al tri­als of the trans­plant­a­tion of em­bryon­ic or foet­al tis­sues and cells, Art­icles 35, 36 and 38 of the Trans­plant­a­tion Or­din­ance ad­di­tion­ally ap­ply.

44 SR 810.211

Previous article Show article in the law Next article

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Gesetzeskürzel Name
DE FR IT EN
DE FR IT EN
Laden